Study of DSP-0390 in Patients With Recurrent High-Grade Glioma
Clinical trial NCT05023551 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05023551
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-08
- Primary completion
- 2027-09-30
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.